given the absence of toxicity the definitely better therapeutic result , and the absence of induced resistance , aztreonam should be considered the drug of choice and should be preferred to aminoglucosides for the management of urinary tract infections due to microorganisms sensitive to both types of drugs in patients with urinary calculosis .
C0004521
aztreonam
C0042029
of urinary tract infections